Moolec Science S.A. (MLEC)
NASDAQ·Healthcare·Biotechnology
$8.67
+7.11%
Mkt Cap $6.30M
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q4 2025 Oct 1, 2025 | $2.01M | — | — | -$0.70 | -$0.70 | +0.00% | — | — |
| Q2 2025 Apr 16, 2025 | $1.31M | — | — | -$0.06 | -$9.00 | -14900.00% | — | — |
| Q2 2025 Apr 10, 2025 | $1.31M | $2.64M | +100.99% | — | -$0.93 | — | — | — |
| Q4 2024 Oct 2, 2024 | $1.31M | $1.56M | +18.95% | -$0.07 | -$10.49 | -14885.71% | — | — |
| Q2 2024 Jun 30, 2024 | — | $1.52M | — | — | -$1.05 | — | — | — |
| Q2 2024 May 30, 2024 | $650.00K | $2.11M | +224.59% | -$0.07 | -$6.00 | -8471.43% | — | — |
| Q1 2024 Mar 13, 2024 | $600.00K | $252.11K | -57.98% | -$7.50 | -$7.50 | +0.00% | — | — |
| Q4 2023 Dec 14, 2023 | $630.00K | $1.74M | +176.20% | -$7.50 | -$6.00 | +20.00% | — | — |
| Q3 2023 Jul 10, 2023 | — | — | — | — | -$0.14 | — | — | — |
| Q2 2023 Jun 30, 2023 | — | $905.05K | — | — | -$1.10 | — | — | — |
| Q4 2022 Dec 31, 2022 | — | — | — | — | -$19.15 | — | — | — |
| Q3 2022 Sep 30, 2022 | — | — | — | — | -$0.24 | — | — | — |
| Q2 2022 Jun 30, 2022 | — | — | — | — | -$0.61 | — | — | — |
| Q1 2022 Mar 31, 2022 | — | — | — | — | -$0.47 | — | — | — |
| Q4 2021 Dec 31, 2021 | — | — | — | — | -$0.13 | — | — | — |
| Q3 2021 Sep 30, 2021 | — | — | — | — | $0.75 | — | — | — |
| Q2 2021 Jun 30, 2021 | — | — | — | — | -$1.61 | — | — | — |
| Q1 2021 Mar 31, 2021 | — | — | — | — | $0.90 | — | — | — |
| Q4 2020 Dec 31, 2020 | — | — | — | — | -$0.00 | — | — | — |